4
Changes in Ownership
PROTHENA CORP PUBLIC LTD CO Filed Acc 0001140361-23-030333
Chief Medical Officer sold 7,331 shares at $74.00 ($542,494)
- Chief Medical Officer acquired 7,331 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Garren Hideki Chief Medical Officer | 2023-06-16 | Option exercise 10b5-1 | +7,331 | $24.90 | $182,542 | 7,331 | D |
| Garren Hideki Chief Medical Officer | 2023-06-16 | Sale 10b5-1 | −7,331 | $74.00 | $542,494 | 0 | D |
| Derivatives | |||||||
| Garren Hideki Chief Medical Officer | 2023-06-16 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −7,331 | 198,000 | D | ||
| Open-market sales · 7,331 sh · avg $74.00 · $542,494 | |||||||
Loading xslF345X04/form4.xml…